Juvenescence

Juvenescence Limited is a British Virgin Islands-based holding company focused on investing in the field of human aging and longevity. With a commitment to developing therapeutics that aim to extend both lifespan and healthspan, Juvenescence has raised significant funding to create a comprehensive ecosystem targeting aging and age-related diseases. The company collaborates with leading scientists and research institutions to in-license compounds and form joint ventures, leveraging recent scientific advancements to produce evidence-based therapies. By addressing the biological causes of aging, Juvenescence aims to develop medical solutions that promote healthy aging, metabolic health, and brain health. Their efforts are positioned to have substantial implications across various sectors, including healthcare and insurance, as they seek to improve the quality of life for an aging population.